よむ、つかう、まなぶ。
参考資料15 COVID-19 vaccine safety update; Primary series in young children and booster doses in older children and adults, ACIP September 1, 2022 (6 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000208910_00052.html |
| 出典情報 | 第85回厚生科学審議会予防接種・ワクチン分科会副反応検討部会、令和４年度第14回薬事・食品衛生審議会薬事分科会医薬品等安全対策部会安全対策調査会（合同開催）（10／7）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Active safety monitoring for COVID-19 vaccines
V-safe is a voluntary CDC smart phone-based monitoring program
for COVID-19 vaccine safety in the United States
▪ Uses text messaging and web surveys to check in with vaccine recipients
after vaccination
▪ Solicits participants’ reports on how they feel after COVID-19 vaccination
• Local injection site reactions (e.g., pain, redness, swelling)
• Systemic reactions (e.g., fatigue, headache, joint pain)
• Health impacts (unable to perform normal daily activities, missed
school or work, or received care)
▪ Parents can register and complete surveys on behalf of their child
6
V-safe is a voluntary CDC smart phone-based monitoring program
for COVID-19 vaccine safety in the United States
▪ Uses text messaging and web surveys to check in with vaccine recipients
after vaccination
▪ Solicits participants’ reports on how they feel after COVID-19 vaccination
• Local injection site reactions (e.g., pain, redness, swelling)
• Systemic reactions (e.g., fatigue, headache, joint pain)
• Health impacts (unable to perform normal daily activities, missed
school or work, or received care)
▪ Parents can register and complete surveys on behalf of their child
6